Influence of tumour condition on the macrophage activity in candida albicans infection

Scandinavian Journal of Immunology

Volumn 70, Issue 1, 2009, Pages 10-17

  Venturini, J ^a   De Camargo, M R ^a   Felix M C ^b   Vilani Moreno, F R ^c   De Arruda, M S P ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Hospital Estadual de Bauru   (Brazil)

^c INSTITUTO LAURO DE SOUZA LIMA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANDIDA ALBICANS; CANDIDIASIS; CELL ACTIVATION; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EHRLICH ASCITES TUMOR; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INFECTION SENSITIVITY; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY; MALE; METABOLISM;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CARCINOMA, EHRLICH TUMOR; HYDROGEN PEROXIDE; MACROPHAGES, PERITONEAL; MALE; MICE; NITRIC OXIDE; OPPORTUNISTIC INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67649801095     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02260.x     Document Type: Article

References (31)

1. Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997 25 : 247 59.
2. Wisplinghoff H, Cornely OA, Moser S et al. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study. Infect Control Hosp Epidemiol 2003 24 : 905 11.
3. Jugo J, Kennedy R, Crowe MJ et al. Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospital. J Hosp Infect 2002 50 : 48 55. (Pubitemid 37554681)
4. Velasco E, Byington R, Martins CA, Schirmer M, Dias LM, Gonçalves VM. Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center. Eur J Clin Microbiol Infect Dis 2003 22 : 137 43.
5. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003 36 : 1103 10.
6. Pasqualotto AC, Rosa DD, Medeiros LR, Severo LC. Candidaemia and cancer: patients are not all the same. BMC Infect Dis 2006 6 : 50.
7. Okawa Y, Kobayashi M, Sakai K, Suzuki M. Role of polymorphonuclear leukocytes in the resistance of tumor-bearing mice against Candida albicans infection. Biol Pharm Bull 2004 27 : 674 8.
8. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005 5 : 953 64.
9. Bhaumik S, Khar A. Cytokine-induced production of no by macrophages induces apoptosis and immunological rejection of ak-5 histiocytic tumor. Apoptosis 1998 3 : 361 8.
10. Bhaumik S, Mitra R, Varalakshmi C, Khar A. Activated macrophages migrate to the subcutaneous tumor site via the peritoneum: a novel route of cell trafficking. Exp Cell Res 2001 266 : 44 52. (Pubitemid 32989041)
11. Dagli MLZ, Guerra JL, Saldiva PHN. An experimental study on the lymphatic dissemination of the solid Ehrlich tumor in mice. Braz J Vet Res Anim Sci 1992 29 : 97 103.
12. Silva RJ, da Silva MG, Vilela LC, Fecchio D. Cytokine profile of Ehrlich ascites tumor treated with Bothrops jararaca venom. Mediators Inflamm 2002 11 : 197 201. (Pubitemid 35155461)
13. Vilani-Moreno FR, Arruda MSP, Escudero H. Candidíase Experimental: estudo comparativo de dois Métodos de coloração vital na determinação da viabilidade dos fungos em suspensão. Salusvita 1999 18 : 139 42.
14. Bagagli E, Sano A, Coelho KI et al. Isolation of Paracoccidioides brasiliensis from armadillos (Dasypus noveminctus) captured in an endemic area of paracoccidioidomycosis. Am J Trop Med Hyg 1998 58 : 505 12.
15. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982 126 : 131 8.
16. Russo M, Teixeira HC, Marcondes MC, Barbuto JA. Superoxide-independent hydrogen peroxide release by activated macrophages. Braz J Med Biol Res 1989 22 : 1271 3.
17. Norman GR, Streiner DL. Biostatistics - The Base Essentials. St. Louis, MO : Mosby Year Book, 1994.
18. Elgert KD, Alleva DG, Mullins DW. Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 1998 64 : 275 90.
19. Tavares D, Ferreira P, Arala-Chaves M. Increased resistance to systemic candidiasis in athymic or interleukin-10-depleted mice. J Infect Dis 2000 182 : 266 73.
20. Monti P, Leone BE, Zerbi A et al. Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell. J Immunol 2004 172 : 7341 9.
21. Kuang DM, Wu Y, Chen N, Cheng J, Zhuang SM, Zheng L. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 2007 110 : 587 95.
22. Pitarch A, Díez-Orejas R, Molero G et al. Analysis of the serologic response to systemic Candida albicans infection in a murine model. Proteomics 2001 1 : 550 9.
23. Elahi S, Pang G, Clancy R, Ashman RB. Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis. Infect Immun 2000 68 : 5771 7.
24. Ashman RB. Murine candidiasis: susceptibility is associated with the induction of T cell-mediated, strain-specific autoreactivity. Immunol Cell Biol 1990 68 : 179 85.
25. Elahi S, Pang G, Ashman Rb, Clancy R. Nitric oxide-enhanced resistance to oral candidiasis. Immunology 2001 104 : 447 54.
26. Blasi E, Pitzurra L, Puliti M et al. Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds. Infect Immun 1995 63 : 1806 9.
27. Schröppel K, Kryk M, Herrmann M, Leberer E, Röllinghoff M, Bogdan C. Suppression of type 2 NO-synthase activity in macrophages by Candida albicans. Int J Med Microbiol 2001 290 : 659 68.
28. Naama HA, McCarter MD, Mack VE et al. Suppression of macrophage nitric oxide production by melanoma: mediation by a melanoma-derived product. Melanoma Res 2001 11 : 229 38.
29. Balish E, Warner TF, Nicholas PJ, Paulling EE, Westwater C, Schofield DA. Susceptibility of germfree phagocyte oxidase and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin. Infect Immun 2005 73 : 1313 20.
30. Enjalbert B, MacCallum DM, Odds FC, Brown AJ. Niche-specific activation of the oxidative stress response by the pathogenic fungus Candida albicans. Infect Immun 2007 75 : 2143 51.
31. Mitra R, Dharajiya N, Kumari L, Varalakshmi C, Khar A. Migration of antigen presenting cells from periphery to the peritoneum during an inflammatory response: role of chemokines and cytokines. FASEB J 2004 18 : 1764 6.